Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil (2015)
- Authors:
- USP affiliated authors: NOVAES, HILLEGONDA MARIA DUTILH - FM ; SARTORI, ANA MARLI CHRISTOVAM - FM
- Unidade: FM
- DOI: 10.1016/j.vaccine.2014.12.031
- Subjects: VACINAÇÃO; HPV; NEOPLASIAS UTERINAS; MENINAS
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
NOVAES, Hillegonda Maria Dutilh et al. Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil. Vaccine, v. 33S, p. A135-A142, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2014.12.031. Acesso em: 27 jan. 2026. -
APA
Novaes, H. M. D., Soárez, P. C. de, Silva, G. A., Ayres, A., Itria, A., Rama, C. H., et al. (2015). Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil. Vaccine, 33S, A135-A142. doi:10.1016/j.vaccine.2014.12.031 -
NLM
Novaes HMD, Soárez PC de, Silva GA, Ayres A, Itria A, Rama CH, Sartori AMC, Clarkf AD, Resch S. Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil [Internet]. Vaccine. 2015 ; 33S A135-A142.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1016/j.vaccine.2014.12.031 -
Vancouver
Novaes HMD, Soárez PC de, Silva GA, Ayres A, Itria A, Rama CH, Sartori AMC, Clarkf AD, Resch S. Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil [Internet]. Vaccine. 2015 ; 33S A135-A142.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1016/j.vaccine.2014.12.031 - Cost-Effectiveness Analysis of Incorporation of the HPV Vaccine to the National Immunization Program / NIP of Brazil
- Avaliação da implantação dos Centros de Referência para Imunobiológicos Especiais
- National Spending with Screening, Diagnosis and Treatment of Cervical Cancer: Estimates Based on Health Information Systems, Brazil, 2006
- Systematic review of economic evaluations of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in individuals 60 years of age or older
- Revisão sistemática das diretrizes de análise de impacto
- Challenges of interpreting epidemiologic surveillance pertussis data with changing diagnostic and immunization practices: the case of the state of Sao Paulo, Brazil
- Systematic review of cost-effectiveness of vaccinating elderly whit the 23-valent pneumococcal polysaccharide vaccine (PPV23)
- Cost-Effectiveness Analysis of Universal Vaccination of Adults Aged 60 Years with 23-Valent Pneumococcal Polysaccharide Vaccine versus Current Practice in Brazil
- Vaccines are different: A systematic review of budget impact analyses of vaccines
- Polio inactivated vaccine costs into routine childhood immunization in Brazil
Informações sobre o DOI: 10.1016/j.vaccine.2014.12.031 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
